Decision Support Among Surrogate Decision Makers of the Chronically Critically Ill (INVOLVE)
- Conditions
- Critical Illness
- Interventions
- Behavioral: Informational SupportBehavioral: Usual CareBehavioral: INVOLVE
- Registration Number
- NCT03099746
- Lead Sponsor
- Case Western Reserve University
- Brief Summary
Each year, millions of Americans are admitted to an intensive care unit (ICU). For more than half of them, ICU admission initiates a cascade of decisions about treatment and end-of-life care.This is particularly the case for patients with chronic critical illness, a life-limiting syndrome. Most (74%-82%) ICU patients who require mechanical ventilation have transient or persistent cognitive impairment that precludes them from making their own healthcare decisions. Among ICU patients, the chronically critically ill (CCI) are at highest risk for cognitive impairment and thus require a surrogate decision maker (SDM), usually a family member. SDMs for the critically ill often describe high states of psychological stress associated with the uncertainty of the patient's condition and their decision making role.
The purpose of this study is to test the effectiveness of two decision support interventions for end-of-life care delivered to SDMs of CCI patients. This will be the first study to test interventions tailored to the unique needs of the SDMs of CCI patients delivered using an interactive avatar based format.
- Detailed Description
The investigators will conduct a three-arm unblinded clinical trial using pre- and post-tests to evaluate the efficacy of two electronic decision-support interventions, Interactive Virtual Decision Support for End-of-Life and Palliative Care (INVOLVE) and Informational Support (IS), compared to each other and to usual care (UC) among 270 SDMs of cognitively impaired CCI patients. This design will allow the investigators to prospectively compare the efficacy of the experiential avatar-based decision support tool (INVOLVE) with both an information-only condition and UC. Subjects assigned to an experimental condition (INVOLVE or IS) will receive two doses of the intervention, at enrollment and 1 day later. After the second dose, these subjects will have access to their assigned condition for subsequent self-administered doses, which will be electronically captured until the patient's ICU discharge or death. Data will be collected at (T1) baseline (Day 3 or 4 of the patient's ICU stay), and then on Days 1, 3, 7 and 90 post-baseline
.
The investigators aim to:
1. Identify the essential elements of the graphical user interface and educational content needed to revise the INVOLVE prototype for a set of common end-of-life decisions that occur in the ICU.
2. Evaluate if there are differences in the decision making readiness and decision making quality between subjects exposed to INVOLVE, IS, or UC on Days 1, 3, and 7 days post-baseline while accounting for covariates (prior SDM experience, SDM knowledge of the patient's preferences, and SDM's religious beliefs).
3. Determine if there are differences in the post-decision outcomes of SDMs and their CCI patient by study condition while accounting for covariates at 90 days post-baseline.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 281
Eligibility criteria for CCI patients:
- aged 18 years or older
- required mechanical ventilation and ICU stay for greater than or equal to 3 days
- not expected to be transferred out of the ICU within 48 hours
- lacks cognitive capacity, as determined by a Glasgow Coma Scale eye score of less than 3 or the motor score less than 6 and verifying the status by asking the patients's attending physician or advanced practice nurse whether he or she would obtain consent from the patient or a family member
- has an identified SDM (next-of-kin or legal representative for healthcare decision making).
Eligibility criteria for SDMs:
- aged 18 years or older
- identified by the healthcare team as the patient's next of kin or legal representative for healthcare decision making
- able to speak and understand English
- able to view images on an 10-inch computer screen and hear audio through a standard set of headphones.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Informational Support Informational Support The second condition, called Informational Support (IS), will also be administered via tablet computers and expose SDMs to educational resources of INVOLVE without the experiential components. Usual Care Usual Care The third condition, usual care (UC), will expose SDMs to the routine communication and decisional support practices provided by the healthcare team. INVOLVE INVOLVE The first study condition, called "Interactive Virtual Decision Support for End-of-Life and Palliative Care (INVOLVE)" will consist of exposures to an avatar-based decision support technology that will be administered via tablet computer and allow SDMs opportunities to practice their communication and decision making skills through interactions with avatars that portray a decision coach and various healthcare providers.
- Primary Outcome Measures
Name Time Method Repeated Measures From (T1) baseline through (T5) 90 days post-baseline ANOVA Model (F-Statistic)
- Secondary Outcome Measures
Name Time Method Change in Preparation for Decision Making Scale (T1) baseline through (T4) 7 days post-baseline Measure of Decision Making Preparedness
Change in Family Decision Making Self-Efficacy Scale (T1) baseline through (T4) 7 days post-baseline Measure of Decision Making Self-Efficacy
Change in Decision Conflict Scale (T1) baseline through (T4) 7 days post-baseline Measure of Decision Conflict
Change in Modified Control Preferences Scale (T1) baseline through (T4) 7 days post-baseline Measure of Behavioral Activation
Change in Single item measure of Role Stress (T1) baseline through (T4) 7 days post-baseline Measure of Decisional Role Stress
Change in Decision Regret Scale (T1) baseline and (T5) 90 days post-baseline Measure of Decision Regret
Change in Hospital Anxiety and Depression Scale (T1) baseline and (T5) 90 days post-baseline Measure of Anxiety and Depressive Symptoms
Trial Locations
- Locations (1)
University Hospitals Case Medical Center
🇺🇸Cleveland, Ohio, United States